2024-10-09 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $52.58 | $525,783 | +3.85% | |
2024-10-08 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $54.00 | $539,961 | -3.11% | |
2024-09-26 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $56.10 | $560,970 | +1.52% | |
2024-09-25 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $56.34 | $563,370 | +1.09% | |
2024-09-24 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $58.21 | $582,100 | -2.16% | |
2024-09-12 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $59.20 | $592,030 | -6.44% | |
2024-09-11 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $59.09 | $590,870 | +2.46% | |
2024-09-10 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $59.09 | $590,890 | -4.14% | |
2024-08-15 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $57.95 | $579,490 | 0% | |
2024-08-14 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $57.25 | $572,471 | 0% | |
2024-08-13 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $56.25 | $562,490 | 0% | |
2023-08-31 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $42.82 | $428,170 | -6.65% | |
2023-08-30 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $42.85 | $428,540 | -7.52% | |
2023-08-29 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $42.40 | $424,020 | -7.77% | |
2023-08-17 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $43.18 | $431,820 | -6.47% | |
2023-08-16 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $43.53 | $435,320 | -8.18% | |
2023-08-15 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $43.77 | $437,680 | -9.65% | |
2023-07-27 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $43.79 | $437,900 | -9.71% | |
2023-07-26 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $42.69 | $426,890 | -7.33% | |
2023-07-25 | Sale | Halozyme Therapeutics, Inc. HALO | PRESIDENT AND CEO | | $42.80 | $427,960 | -6.98% | |